Access the full text.
Sign up today, get DeepDyve free for 14 days.
Amy McKee, A. Markon, K. Chan-Tack, P. Lurie (2017)
How Often Are Drugs Made Available Under the Food and Drug Administration's Expanded Access Process Approved?The Journal of Clinical Pharmacology, 57
J. Jarow, S. Lemery, Kevin Bugin, S. Khozin, R. Moscicki (2016)
Expanded Access of Investigational Drugs: The Experience of the Center of Drug Evaluation and Research Over a 10-Year PeriodTherapeutic Innovation & Regulatory Science, 50
K. Traynor (2018)
Federal right-to-try law aims to broaden access to investigational drugs.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 75 15
Michael Hoerger (2016)
Right-to-try laws and individual patient “compassionate use” of experimental oncology medications: A call for improved provider-patient communicationDeath Studies, 40
M. Holbein, J. Berglund, K. Weatherwax, D. Gerber, J. Adamo (2015)
Access to Investigational Drugs: FDA Expanded Access Programs or “Right‐to‐Try” Legislation?Clinical and Translational Science, 8
This study assesses the outcomes of single-patient use of the US Food and Drug Administration Expanded Access program.
JAMA Oncology – American Medical Association
Published: Apr 28, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.